missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant SARS-CoV-2 Spike RBD Fc Chimera Protein, CF
HEK293 Expressed, High ACE-2 Binding
Brand: R&D Systems™ 10499-CV-100
This item is not returnable.
View return policy
Description
Measured by its binding ability in a functional ELISA with Recombinant Human ACE-2 His-tag (Catalog # 933-ZN ). Measured by its binding ability in a functional ELISA with Recombinant Human EMMPRIN/CD147 Fc Chimera (Catalog # 972-EMN ).Specifications
YP_009724390.1 | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. | |
100 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
Unconjugated | |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
Bioactivity | |
M.W. (Observed): 55-66 kDa, under reducing conditions, M.W. (Theoretical): 52 kDa | |
Human embryonic kidney cell, HEK293-derived sars-cov-2 Spike RBD protein SARS-CoV2 Spike RBD (Arg319-Phe541) (N-terminus) Accession # YP_009724390.1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
<0.10 EU per 1 μg of the protein by the LAL method. | |
Reconstitute at 500 μg/mL in PBS. | |
Spike RBD |